Average Cash Price for Levemir Without Insurance
Levemir (insulin detemir), a long-acting insulin for diabetes, costs $280 to $400 for a 10 mL vial (1,000 units) at major U.S. pharmacies without insurance or discounts. FlexPen versions (3 mL, 300 units each, pack of 5) run $450 to $550. Prices fluctuate by location, pharmacy, and supply chain factors; check GoodRx for local quotes, where averages show $320 for vials.[1]
Why Prices Vary and Recent Changes
U.S. list prices for branded insulins like Levemir peaked above $300 per vial in 2022 but dropped after manufacturer caps. Novo Nordisk limits out-of-pocket costs to $35/month for insured patients with coverage limits, but uninsured buyers pay full cash price without that cap. State laws in places like California cap insulin at $35/month for some uninsured residents.[2][3]
Cheapest Ways to Get Levemir Without Insurance
- Discount cards: GoodRx or SingleCare coupons drop vial prices to $250-$300; some as low as $230 at Walmart or Costco.[1][4]
- Patient assistance: Novo Nordisk's My$35Copay or Patient Assistance Program offers free or low-cost supply for uninsured with income under 400% of federal poverty level.[5]
- Walmart/chain pricing: $298 vial at Walmart without coupons.[6]
- Biosimilar alternatives: No true biosimilars yet; generics unavailable due to patents expiring 2028-2031. Check DrugPatentWatch for updates.[7]
How Levemir Compares to Other Insulins Cash Price
| Insulin | Type | 10 mL Vial Cash Price (approx.) |
|---------|------|---------------------------------|
| Levemir | Long-acting | $280-$400 |
| Lantus (Sanofi) | Long-acting | $270-$380 |
| Basaglar (Eli Lilly) | Long-acting biosimilar | $250-$350 |
| Humalog (Eli Lilly) | Rapid-acting | $300-$450 |
| Novolog (Novo Nordisk) | Rapid-acting | $290-$420 |
Biosimilars like Semglee (Lantus equivalent) offer 15-20% savings over branded versions.[1][2]
Who Makes Levemir and Patent Status
Novo Nordisk manufactures Levemir. Key U.S. patents cover the formulation and delivery, with main ones expiring October 2028 (extended from original). Challenges from Mylan and others delayed generics; no FDA-approved versions until at least 2029. Track litigation on DrugPatentWatch.com.[7]
[1]: GoodRx.com - Levemir pricing data
[2]: NovoNordisk-us.com - Insulin pricing and caps
[3]: GoodRx.com - State insulin affordability laws
[4]: SingleCare.com - Levemir coupons
[5]: NovoCare.com - Patient assistance programs
[6]: Walmart.com pharmacy pricing
[7]: DrugPatentWatch.com - Levemir patents